These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33601149)

  • 1. A review on the role of oncogenic lncRNA OIP5-AS1 in human malignancies.
    Ghafouri-Fard S; Dashti S; Farsi M; Hussen BM; Taheri M
    Biomed Pharmacother; 2021 May; 137():111366. PubMed ID: 33601149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA OIP5-AS1 promotes proliferation of lung cancer cells and leads to poor prognosis by targeting miR-378a-3p.
    Wang M; Sun X; Yang Y; Jiao W
    Thorac Cancer; 2018 Aug; 9(8):939-949. PubMed ID: 29897167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kockdown of OIP5-AS1 expression inhibits proliferation, metastasis and EMT progress in hepatoblastoma cells through up-regulating miR-186a-5p and down-regulating ZEB1.
    Zhang Z; Liu F; Yang F; Liu Y
    Biomed Pharmacother; 2018 May; 101():14-23. PubMed ID: 29475118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA opa-interacting protein 5 antisense transcript 1 promotes proliferation and invasion through elevating integrin α6 expression by sponging miR-143-3p in cervical cancer.
    Yang J; Jiang B; Hai J; Duan S; Dong X; Chen C
    J Cell Biochem; 2019 Jan; 120(1):907-916. PubMed ID: 30188591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA OPA-interacting protein 5 antisense transcript 1 upregulated SMAD3 expression to contribute to metastasis of cervical cancer by sponging miR-143-3p.
    Chen X; Xiong D; Yang H; Ye L; Mei S; Wu J; Chen S; Shang X; Wang K; Huang L
    J Cell Physiol; 2019 Apr; 234(4):5264-5275. PubMed ID: 30341904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. lncRNA OIP5-AS1 Suppresses Cell Proliferation and Invasion of Endometrial Cancer by Regulating PTEN/AKT via Sponging miR-200c-3p.
    Liu Y; Cai X; Cai Y; Chang Y
    J Immunol Res; 2021; 2021():4861749. PubMed ID: 34368370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA OIP5-AS1 plays an oncogenic role in ovarian cancer through targeting miR-324-3p/NFIB axis.
    Liu QY; Jiang XX; Tian HN; Guo HL; Guo H; Guo Y
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7266-7275. PubMed ID: 32706064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA OIP5-AS1 promotes pancreatic cancer cell growth through sponging miR-342-3p via AKT/ERK signaling pathway.
    Meng X; Ma J; Wang B; Wu X; Liu Z
    J Physiol Biochem; 2020 May; 76(2):301-315. PubMed ID: 32157498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA OIP5-AS1 promotes the progression of oral squamous cell carcinoma via regulating miR-338-3p/NRP1 axis.
    Li M; Ning J; Li Z; Fei Q; Zhao C; Ge Y; Wang L
    Biomed Pharmacother; 2019 Oct; 118():109259. PubMed ID: 31369989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA OIP5-AS1 serves as an oncogene in laryngeal squamous cell carcinoma by regulating miR-204-5p/ZEB1 axis.
    Wang H; Qian J; Xia X; Ye B
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2177-2184. PubMed ID: 32009213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA OIP5-AS1 promotes the growth of gastric cancer through the miR-367-3p/HMGA2 axis.
    Tao Y; Wan X; Fan Q; Wang Y; Sun H; Ma L; Sun C; Wu Y
    Dig Liver Dis; 2020 Jul; 52(7):773-779. PubMed ID: 31959478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA OIP5-AS1 induces epithelial-to-mesenchymal transition and renal fibrosis in diabetic nephropathy via binding to miR-30c-5p.
    Fu JX; Sun GQ; Wang HL; Jiang HX
    J Biol Regul Homeost Agents; 2020; 34(3):961-968. PubMed ID: 32519534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA OIP5-AS1 functions as an oncogene in lung adenocarcinoma through targeting miR-448/Bcl-2.
    Deng J; Deng H; Liu C; Liang Y; Wang S
    Biomed Pharmacother; 2018 Feb; 98():102-110. PubMed ID: 29247949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lncRNA OIP5-AS1 targets ROCK1 to promote cell proliferation and inhibit cell apoptosis through a mechanism involving miR-143-3p in cervical cancer.
    Song L; Wang L; Pan X; Yang C
    Braz J Med Biol Res; 2020; 53(1):e8883. PubMed ID: 31939597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA OIP5-AS1 regulates radioresistance by targeting DYRK1A through miR-369-3p in colorectal cancer cells.
    Zou Y; Yao S; Chen X; Liu D; Wang J; Yuan X; Rao J; Xiong H; Yu S; Yuan X; Zhu F; Hu G; Wang Y; Xiong H
    Eur J Cell Biol; 2018 Jun; 97(5):369-378. PubMed ID: 29773344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulating lncRNA OIP5-AS1 protects neuron injury against cerebral hypoxia-ischemia induced inflammation and oxidative stress in microglia/macrophage through activating CTRP3 via sponging miR-186-5p.
    Chen Y; Liu W; Chen M; Sun Q; Chen H; Li Y
    Int Immunopharmacol; 2021 Mar; 92():107339. PubMed ID: 33516048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA OIP5-AS1 interacts with miR-363-3p to contribute to hepatocellular carcinoma progression through up-regulation of SOX4.
    Wang J; Tang Q; Lu L; Luo Z; Li W; Lu Y; Pu J
    Gene Ther; 2019 Nov; 27(10-11):495-504. PubMed ID: 32042127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OIP5-AS1 promotes the progression of gastric cancer cells via the miR-153-3p/ZBTB2 axis.
    Zhi XH; Jiang K; Ma YY; Zhou LQ
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2428-2441. PubMed ID: 32196594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA OIP5-AS1 facilitates gastric cancer cell growth by targeting the miR-422a/ANO1 axis.
    Xie R; Liu L; Lu X; Hu Y
    Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):430-438. PubMed ID: 32147682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA OIP5-AS1 mediates resistance to doxorubicin by regulating miR-137-3p/PTN axis in osteosarcoma.
    Sun X; Tian C; Zhang H; Han K; Zhou M; Gan Z; Zhu H; Min D
    Biomed Pharmacother; 2020 Aug; 128():110201. PubMed ID: 32460190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.